» Articles » PMID: 35474104

Epitranscriptomic Dynamics in Brain Development and Disease

Overview
Journal Mol Psychiatry
Date 2022 Apr 27
PMID 35474104
Authors
Affiliations
Soon will be listed here.
Abstract

Distinct cell types are generated at specific times during brain development and are regulated by epigenetic, transcriptional, and newly emerging epitranscriptomic mechanisms. RNA modifications are known to affect many aspects of RNA metabolism and have been implicated in the regulation of various biological processes and in disease. Recent studies imply that dysregulation of the epitranscriptome may be significantly associated with neuropsychiatric, neurodevelopmental, and neurodegenerative disorders. Here we review the current knowledge surrounding the role of the RNA modifications N6-methyladenosine, 5-methylcytidine, pseudouridine, A-to-I RNA editing, 2'O-methylation, and their associated machinery, in brain development and human diseases. We also highlight the need for the development of new technologies in the pursuit of directly mapping RNA modifications in both genome- and single-molecule-level approach.

Citing Articles

The interplay between epitranscriptomic RNA modifications and neurodegenerative disorders: Mechanistic insights and potential therapeutic strategies.

Hashmi M, Fatima H, Ahmad S, Rehman A, Safdar F Ibrain. 2024; 10(4):395-426.

PMID: 39691424 PMC: 11649393. DOI: 10.1002/ibra.12183.


RNA methylation in neurodevelopment and related diseases.

Xia W, Liu Y, Lu J, Cheung H, Meng Q, Huang B Acta Biochim Biophys Sin (Shanghai). 2024; 56(12):1723-1732.

PMID: 39344412 PMC: 11693867. DOI: 10.3724/abbs.2024159.


Loss-of-function variants in RNA binding motif protein X-linked induce neuronal defects contributing to amyotrophic lateral sclerosis pathogenesis.

He D, He X, Shen D, Liu L, Yang X, Hao M MedComm (2020). 2024; 5(9):e712.

PMID: 39263607 PMC: 11387721. DOI: 10.1002/mco2.712.


Emerging Role of Environmental Epitranscriptomics and RNA Modifications in Parkinson's Disease.

Gionco J, Bernstein A J Parkinsons Dis. 2024; 14(4):643-656.

PMID: 38578904 PMC: 11191529. DOI: 10.3233/JPD-230457.


N-methylation in the development, diagnosis, and treatment of gastric cancer.

Wang J, Zhao G, Zhao Y, Zhao Z, Yang S, Zhou A J Transl Int Med. 2024; 12(1):5-21.

PMID: 38525439 PMC: 10956730. DOI: 10.2478/jtim-2023-0103.


References
1.
Boccaletto P, Machnicka M, Purta E, Piatkowski P, Baginski B, Wirecki T . MODOMICS: a database of RNA modification pathways. 2017 update. Nucleic Acids Res. 2017; 46(D1):D303-D307. PMC: 5753262. DOI: 10.1093/nar/gkx1030. View

2.
Tang C, Klukovich R, Peng H, Wang Z, Yu T, Zhang Y . ALKBH5-dependent m6A demethylation controls splicing and stability of long 3'-UTR mRNAs in male germ cells. Proc Natl Acad Sci U S A. 2017; 115(2):E325-E333. PMC: 5777073. DOI: 10.1073/pnas.1717794115. View

3.
Zhou K, Shi H, Lyu R, Wylder A, Matuszek Z, Pan J . Regulation of Co-transcriptional Pre-mRNA Splicing by mA through the Low-Complexity Protein hnRNPG. Mol Cell. 2019; 76(1):70-81.e9. PMC: 6778029. DOI: 10.1016/j.molcel.2019.07.005. View

4.
Yang X, Yang Y, Sun B, Chen Y, Xu J, Lai W . 5-methylcytosine promotes mRNA export - NSUN2 as the methyltransferase and ALYREF as an mC reader. Cell Res. 2017; 27(5):606-625. PMC: 5594206. DOI: 10.1038/cr.2017.55. View

5.
Wang X, Lu Z, Gomez A, Hon G, Yue Y, Han D . N6-methyladenosine-dependent regulation of messenger RNA stability. Nature. 2013; 505(7481):117-20. PMC: 3877715. DOI: 10.1038/nature12730. View